|Dec 2014||Dec 2013||Dec 2012||Dec 2011|
|Cash Flow From Operating Activities|
|Net Income (Loss)||4.41B||9.28B||7.67B||8.47B|
|Extraordinary Gains / Losses||0.00||0.00||0.00||0.00|
|(Increase) Decrease In Receivables||687.96M||-333.10M||252.10M||190.97M|
|(Increase) Decrease in Inventories||-823.37M||-156.65M||59.79M||-243.76M|
|(Increase) Decrease In Other Current Assets||0.00||0.00||0.00||0.00|
|(Decrease) Increase In Payables||141.64M||206.12M||286.03M||686.25M|
|(Decrease) Increase In Other Current Liabilities||0.00||0.00||0.00||-3.39B|
|(Increase) Decrease In Other Working Capital||1.02B||375.97M||-4.52B||3.11M|
|Other Non-Cash Items||986.80M||3.12B||1.68B||3.06B|
|Net Cash From Continuing Operations||8.06B||11.91B||7.07B||9.70B|
|Net Cash From Discontinued Operations||0.00||0.00||0.00||0.00|
|Cash Provided By Investing Activities|
|Net Cash From Total Operating Activities||8.06B||11.91B||7.07B||9.70B|
|Sale of Property, Plant & Equipment||574.34M||300.12M||1.82B||523.23M|
|Cash Used for Investing Activities|
|Sale of Short-Term Investments||1.56M||24.73M||0.00||46.58M|
|Purchases of Property, Plant & Equipment||-2.73B||-2.80B||-2.46B||-2.06B|
|Purchases of Short-Term Investments||0.00||0.00||0.00||0.00|
|Other Cash from Investing Activities||105.84M||126.97M||114.74M||1.68B|
|Cash Provided by Financing Activities|
|Net Cash From Investing Activities||-1.68B||864.07M||-4.25B||-173.89M|
|Issuance of Debt||3.05B||3.15B||9.98B||69.87M|
|Cash Used for Financing Activities|
|Issuance of Capital Stock||259.93M||964.66M||669.03M||458.02M|
|Repayment of Long-Term Debt||-2.70B||-3.09B||-4.19B||-71.42M|
|Repurchase of Capital Stock||-518.30M||-2.55B||-4.09B||-3.46B|
|Payment of Cash Dividends||-6.30B||-6.07B||-6.44B||-5.65B|
|Other Financing Charges, Net||-2.18B||-2.75B||-1.34B||-1.02B|
|Net Cash From Financing Activities||-8.38B||-10.34B||-5.42B||-9.68B|
|Effect of Exchange Rate Changes||130.74M||-244.05M||-148.67M||-167.68M|
|Net Change in Cash & Cash Equivalents||-1.87B||2.18B||-2.75B||-313.63M|
|Rating||Current||1-Mo Ago||2-Mo Ago||3-Mo Ago|
|GET GSK ANALYST REPORT|
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.